In North America, revenues fell 0.9% amid retailer destocking and weaker consumer confidence, despite share gains driven by innovations in Lysol and Mucinex. Reckitt maintained its full-year ...

Reckitt’s Q1 2025 results indicate a stable start to the year, with overall like-for-like net revenue growth of 1.1%. The company’s core segment experienced a more robust 3.1% growth, thanks to strong ...

Good morning, and welcome to Reckitt's Q1 Trading Update ... of our markets with Lysol Air and Laundry Sanitizers as well as Mucinex recent launches all delivering strong performances and share ...

The site will be used to boost the production of the company's Mucinex cold and flu relief to meet increased demand in the US. Harald Emberger, chief supply officer at Reckitt, said ...

In a report released today, Iain Simpson from Barclays maintained a Hold rating on Reckitt (RKT – Research Report), with a price target of £53.00. The company’s shares closed yesterday at p4 ...

RBC Capital analyst James Edwardes Jones maintained a Buy rating on Reckitt (RKT – Research Report) today and set a price target of £57.00. The company’s shares opened today at p4,810.00.

Lysol maker Reckitt Benckiser Group RKT0.21%increase; green up pointing triangle said the timeline for its plans to unload a portfolio of home-care brands might slip amid market volatility ...

When Reckitt Benckiser Group Plc set out last year to sell a portfolio of homecare brands, including household names such as Air Wick and Cillit Bang, it drew a bevy of private equity suitors ...

(Bloomberg) -- Reckitt Benckiser Plc reported lackluster ... focus on health and hygiene brands like Strepsils lozenges and Mucinex flu remedies. The sale of some home products is on schedule ...